Exos TFP Holdings’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Exos TFP Holdings’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,343	Closed	-$662K	–	640
2022 Q3	$662K	Buy	+66,343	New	+$659K	0.3%	101

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Exos TFP Holdings's PKBO Position: Q4 2022 in Review

Exos TFP Holdings sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 66,343 shares — an estimated $662K sold.

Exos TFP Holdings first reported a position in PKBO in Q3 2022 and held it in 1 quarter. The position peaked at $662K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Exos TFP Holdings reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Exos TFP Holdings sold 66,343 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $662K.
Exos TFP Holdings first reported a position in Peak Bio, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Exos TFP Holdings's Peak Bio, Inc. Common Stock position peaked at $662K in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Exos TFP Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.